QuidelOrtho (QDEL) Net Equity Issued and Repurchased (2021 - 2026)
QuidelOrtho (QDEL) posted Net Equity Issued and Repurchased of $1.8 million for Q1 2026, up 1700.0% sequentially from $100000.0 in Q4 2025, and down 40.0% YoY from $3.0 million in Q1 2025.
QuidelOrtho (QDEL) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
QuidelOrtho has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 40.0% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 34.67% YoY) and the FY2025 annual result came in at $6.1 million, up 22.0% from the prior year.
- Net Equity Issued and Repurchased climbed to $1.8 million in Q1 2026 per QDEL's latest filing, from $100000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $19.1 million in Q1 2023 and troughed at $100000.0 in Q2 2025.
- A 5-year average of $3.4 million and a median of $2.4 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 625.0% in 2025, down 97.56% in 2025.
- Over 5 years, Net Equity Issued and Repurchased stood at $3.5 million in 2022, then changed by 0.0% to $3.5 million in 2023, then plunged by 88.57% to $400000.0 in 2024, then slumped by 75.0% to $100000.0 in 2025, then soared by 1700.0% to $1.8 million in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1.8 million, $100000.0, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | QuidelOrtho | 1.01 Bn | 886.07 Mn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 400,000.00 |
| Jun 28, 2026 | 400,000.00 |
| Mar 29, 2026 | 1.80 Mn |
| Mar 29, 2026 | 1.80 Mn |
| Dec 28, 2025 | 100,000.00 |
| Dec 28, 2025 | 100,000.00 |
| Sep 28, 2025 | 2.90 Mn |
| Sep 28, 2025 | 2.90 Mn |
| Jun 29, 2025 | 100,000.00 |
| Jun 29, 2025 | 100,000.00 |
| Mar 30, 2025 | 3.00 Mn |
| Mar 30, 2025 | 3.00 Mn |
| Sep 29, 2024 | 400,000.00 |
| Sep 29, 2024 | 400,000.00 |
| Jun 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 3.50 Mn |
| Dec 31, 2023 | 3.50 Mn |